WELL-INTEGRATED SCREENING AND EVALUATION FOR WOMEN ACROSS THE NATION (WISEWOMAN)

 

The purpose of this competitive five-year program is to fund state health departments and tribal organizations to extend services to improve prevention, detection, and control of CVD risk factors for low-income, uninsured, or underinsured women by offering CVD screening, risk reduction counseling, referral to medical services, referral to programs, and resources to support positive cardiovascular health.

General information about this opportunity
Last Known Status
Active
Program Number
93.436
Federal Agency/Office
Centers For Disease Control and Prevention, Department of Health and Human Services
Type(s) of Assistance Offered
B - Project Grants
Program Accomplishments
Not applicable.
Authorization
This program is authorized under 42 U.S.C. ยง 300l-1 (2012), sections 1501-1510 [42 U.S.C. 300k, 42 U.S.C. 300l, 42 U.S.C. 300m, 42 U.S.C. 300n, 42 U.S.C. 300 n-1, 42 U.S.C. 300 n-2, 42 U.S.C. 300 n-3, 42 U.S.C. 300 n-4, 42 U.S.C. 300 n-4a, 42 U.S.C. 300 n-5] of the Public Health Service Act, as amended. WISEWOMAN must follow the legislative requirements detailed in these sections
Who is eligible to apply/benefit from this assistance?
Applicant Eligibility
State and the District of Columbia government; local government or their Bona Fide Agent; U.S. Territory or Possession; Federally Recognized Indian Tribal Government; Native American Organization (American Indian/Alaska native tribally designated organization). 1. Eligible Applicants: o State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) . o American Indian/Alaska Native tribal governments (federally recognized or state-recognized) o American Indian/Alaska native tribally designated organizations 2. Special Eligibility Requirements: Applicants must be recipients of the NBCCEDP program funding.
Beneficiary Eligibility
Beneficiaries of this program include: Women who are ages 40-64 and eligible through the National Breast and Cervical Cancer Early Detection Program criteria.
Credentials/Documentation
Not applicable.
What is the process for applying and being award this assistance?
Pre-Application Procedure
Preapplication coordination is required. This program is eligible for coverage under E.O. 12372, "Intergovernmental Review of Federal Programs." An applicant should consult the office or official designated as the single point of contact in his or her State for more information on the process the State requires to be followed in applying for assistance, if the State has selected the program for review. n/a
Application Procedure
This program is excluded from coverage under 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards.
Award Procedure
Review and Selection Process: Applications will be reviewed in three phases. Phase I Review: All applications will be reviewed initially for completeness by CDC OGS staff and will be reviewed jointly for eligibility by the CDC National Center for Chronic Disease Prevention and Health Promotion and CDC OGS. Incomplete applications that do not meet the eligibility criteria will not advance to Phase II review. Phase II Review: This funding opportunity is comprised of two components - Core Component and Innovation Component. Core Component: This competitive Core Component will support the implementation and evaluation of a core set of evidence-based strategies designed to reduce risks, complications, and barriers to the prevention and control of heart disease and stroke among the target population. Applicants must propose a comprehensive work plan that addresses hypertension in alignment with the following broad Strategies indicated in the NOFO. Applicants for the Core Component must propose criteria for selection of health systems and communities in which to work, based on a robust analysis of overall health burden and across population subgroups. Proposals must include clinical and community partners that will support the delivery of services. Letters of support with a firm commitment from providers and partners should be included in the application. Innovation Component: This competitive Innovation Component will support the implementation and evaluation of a small set of innovative strategies designed to reduce risks, complications, and barriers to the prevention and control of heart disease and stroke. All applicants must apply for the Core Component in order to be considered for the Innovation Component. Only those successful applicants under the Core Component will be eligible for Innovation Component funding. Applicants must apply for Innovation Component funding at the same time they make application for Core Component funding. Phase III Review: Applications submitted under the Core Component will be funded by score and rank as determined by the objective review panel. Applications submitted under the Innovation Component will be funded by score and rank determined by the objective review panel. The Selecting official shall rely on the rank order established by the objective review panel as the primary factor in making awards.
Deadlines
Contact the headquarters or regional location, as appropriate for application deadlines
Approval/Disapproval Decision Time
From 120 to 180 days.
Appeals
Not applicable.
Renewals
From 90 to 120 days.
How are proposals selected?
Review and Selection Process: Applications will be reviewed in three phases. Phase I Review: All applications will be reviewed initially for completeness by CDC OGS staff and will be reviewed jointly for eligibility by the CDC National Center for Chronic Disease Prevention and Health Promotion and CDC OGS. Incomplete applications that do not meet the eligibility criteria will not advance to Phase II review. Phase II Review: This funding opportunity is comprised of two components - Core Component and Innovation Component. Core Component: This competitive Core Component will support the implementation and evaluation of a core set of evidence-based strategies designed to reduce risks, complications, and barriers to the prevention and control of heart disease and stroke among the target population. Applicants must propose a comprehensive work plan that addresses hypertension in alignment with the following broad Strategies indicated in the NOFO. Applicants for the Core Component must propose criteria for selection of health systems and communities in which to work, based on a robust analysis of overall health burden and across population subgroups. Proposals must include clinical and community partners that will support the delivery of services. Letters of support with a firm commitment from providers and partners should be included in the application. Innovation Component: This competitive Innovation Component will support the implementation and evaluation of a small set of innovative strategies designed to reduce risks, complications, and barriers to the prevention and control of heart disease and stroke. All applicants must apply for the Core Component in order to be considered for the Innovation Component. Only those successful applicants under the Core Component will be eligible for Innovation Component funding. Applicants must apply for Innovation Component funding at the same time they make application for Core Component funding. Phase III Review: Applications submitted under the Core Component will be funded by score and rank as determined by the objective review panel. Applications submitted under the Innovation Component will be funded by score and rank determined by the objective review panel. The Selecting official shall rely on the rank order established by the objective review panel as the primary factor in making awards.
How may assistance be used?
Funds can be used for salaries for personnel to plan, implement, monitor and evaluate the program activities; for contracts or agreements with clinical entities to provide the cardiovascular screenings; risk reduction counseling; diagnostic office visits for abnormal screening values; contracts or agreements with community based organizations to provide health education and lifestyle support programs, or to improve the health of the physical environment (for example to improve access to healthy food, physical activity, or decrease tobacco exposure); or other activities that promote or support healthy behaviors and improved cardiovascular health in women. Funds can be used to pay for activities or expendable equipment necessary to provide the services outlined here, including self-blood pressure monitoring equipment and counseling to enhance medication adherence. Funds can be used to develop and maintain data collection systems to collect and report biomeasures and behavior information and for monitoring systems to augment control of hypertension.
What are the requirements after being awarded this opportunity?
Reporting
Performance Reports: Annual performance progress and monitoring reports will be expected from all awardees no later than 120 days prior to the end of each budget period. This report will serve as the continuation application for the follow-on budget period. The contents of the report should include the information specified in the solicitation from the CDC Grants Management Officer.
Auditing
Not applicable.
Records
CDC requires awardees to meet all record retention requirements defined in the notice of award, the funding opportunity, the HHS grants policy statement, and 45 CFR Part 75.
Other Assistance Considerations
Formula and Matching Requirements
Statutory formula is not applicable to this assistance listing.

Matching is voluntary. In preparing budgets, applicants must include financial participation described below. Recipient financial participation is required for this program in accordance with the authorizing legislation. Section 1502(a) and (b)(1), (2), and (3) of the PHS Act, as amended, requires matching funds from non-Federal sources in an amount not less than one dollar for every three dollars of Federal funds, a ratio of 3:1, awarded under this program. However, Title 48 of the US Code 1469a (d) requires DHHS to waive matching fund requirements for Guam, U.S. Virgin Islands, American Samoa, and the Commonwealth of the Northern Mariana Islands up to $200,000. The match requirement may include third-party in-kind contributions, as well as expenditures from the grantee. The matching funds may be cash, in-kind or donated services or equipment. Public Law 93-638 authorizes tribal organizations contracting under the authority of Title I to use funds received under the Indian Self-Determination Act as matching funds. Matching funds may not include: 1) payment for treatment services or the donation of treatment services; 2) services assisted or subsidized by the Federal government; or 3) the indirect or overhead costs of an organization. All costs designated as meeting the match requirement must be documented by the applicant and will be subject to audit. Documentation of appropriate matching is to be provided in the detailed budget and narrative justification.

MOE requirements are not applicable to this assistance listing.
Length and Time Phasing of Assistance
Funding for this program will be awarded on annual basis and the funding will be available for obligation by recipients for a period of 12-months Method of awarding/releasing assistance: Lump.
Who do I contact about this opportunity?
Regional or Local Office
None/Not specified.
Headquarters Office
Rebekah Buckley
4770 Buford Highway, MS-F75
Atlanta, GA 30341 US
eut9@cdc.gov
Phone: 7704886215
Website Address
http://www.cdc.gov
Financial Information
Account Identification
75-0943-0-1-550
Obligations
(Cooperative Agreements (Discretionary Grants)) FY 18$16,700,000.00; FY 19 est $16,700,000.00; FY 20 est $16,700,000.00; FY 17$14,549,174.00; - This funding supports DP18-1816
Range and Average of Financial Assistance
Awards are expected to range from $500,000 to $2,500,000 (total award for both Core and innovation Components, were applicable). All activities supported through this NOFO must contribute to health improvements across the target population and across population subgroups. Award recipients must demonstrate significant disease burden to allow the strategies supported by this NOFO to reach a significant proportion of the target population. Funding strategy will also include the awardees' proposed activities and goals, estimated population reach, and program capacity as described in the application.
Regulations, Guidelines and Literature
Not applicable.
Examples of Funded Projects
Not applicable.

 



Federal Grants Resources